EPROI SiriusT3 Physicochemical Property Analyzer

Overview

The EPROI SiriusT3 Physicochemical Property Analyzer is a dedicated, benchtop platform engineered for high-precision, automated determination of fundamental physicochemical parameters critical to early-stage drug discovery and development. Operating on dual orthogonal measurement principles—UV-Vis spectrophotometric titration and potentiometric titration—the SiriusT3 quantifies ionization behavior (pKa), lipophilicity (logP and logD at multiple pH values), intrinsic solubility, and pH-solubility profiles with microgram-scale sample consumption. Its architecture is grounded in thermodynamically rigorous models of acid–base equilibria and partitioning thermodynamics, enabling robust interpretation of molecular behavior across physiological pH gradients (1.0–12.0). Designed explicitly for pharmaceutical R&D labs, the system supports ICH Q5C stability-indicating characterization and aligns with regulatory expectations for preformulation data packages under FDA Guidance for Industry (2022) and EMA CHMP Reflection Paper on Biopharmaceutics Classification System (BCS)-based biowaivers.

Key Features

• Microsample capability: Requires ≤20 µg of compound per full pKa/logD/solubility profile, minimizing synthetic burden and enabling analysis of scarce intermediates.
• Dual-method pKa determination: UV-based titration for chromophore-containing compounds (detection limit: 1–5 µM); potentiometric titration for non-UV-active or highly colored molecules (resolution: ±0.05 pH units).
• Automated logD_7.4 and logP profiling: Measures distribution coefficients across octanol/buffer systems using validated UV calibration curves and internal standard correction.
• Integrated solubility mapping: Generates pH-dependent solubility curves with detection of amorphous precipitation onset, supersaturation ratio (SR), and liquid–liquid phase separation (LLPS) boundaries via real-time UV absorbance monitoring.
• High-throughput operation: Fully automated 96-well plate handling enables unattended analysis of up to 80 samples per 24-hour cycle, including method selection, dilution, titration, and data processing.
• Five-microprobe sensor array: Simultaneous measurement of pH, temperature, UV absorbance (210–400 nm), conductivity, and turbidity within a single 1 mL sample cell—ensuring kinetic coherence and eliminating inter-probe time lag artifacts.

Sample Compatibility & Compliance

The SiriusT3 accommodates APIs, prodrugs, salts, co-crystals, and early-stage screening libraries—including low-solubility BCS Class II/IV compounds, zwitterions, and weakly ionizable bases (pKa 2–11). It supports aqueous buffers (phosphate, citrate, acetate), mixed solvent systems (e.g., 10% DMSO/water), and biorelevant media (FaSSIF/FeSSIF). All measurements comply with ASTM E2912-21 (Standard Guide for pKa Determination by Potentiometric Titration) and ISO 11929:2019 (Evaluation of measurement data). Audit trails, electronic signatures, and instrument qualification documentation meet FDA 21 CFR Part 11 and EU Annex 11 requirements for GLP/GMP environments.

Software & Data Management

SiriusControl™ v5.2 software provides intuitive workflow-driven method setup, real-time curve visualization, and automated parameter extraction using nonlinear regression fitting (Levenberg–Marquardt algorithm). Raw data (absorbance vs. pH, emf vs. volume) are stored in vendor-neutral HDF5 format with embedded metadata (timestamp, operator ID, calibration history). The system exports reports compliant with CDISC SEND standards and integrates with LIMS via ASTM E1482-compliant XML export. Full traceability includes version-controlled method templates, change logs, and retrospective reprocessing without raw data modification.

Applications

• Lead optimization: Correlating pKa shifts with structural modifications to modulate membrane permeability and metabolic stability.
• Formulation risk assessment: Predicting precipitation kinetics during gastric transit using supersaturation ratio (SR) and nucleation induction time derived from solubility-pH profiles.
• BCS classification: Generating logD_7.4 and intrinsic solubility data required for biowaiver justification.
• Salts and co-crystal screening: Quantifying pKa differences (ΔpKa) between API and counterion to assess salt formation propensity.
• PK/PD modeling input: Supplying physicochemical inputs for PBPK simulators (e.g., GastroPlus®, Simcyp®) including ionization-corrected distribution coefficients and pH-partitioning profiles.

FAQ

Does the SiriusT3 support non-aqueous titrations?
Yes—it accommodates acetonitrile, methanol, and ethanol-based titrations for highly lipophilic compounds, with custom electrode conditioning protocols and solvent-specific calibration routines.
Can it measure pKa of compounds with overlapping ionization steps?
Yes—multivariate curve resolution (MCR-ALS) algorithms deconvolute overlapping spectral transitions, enabling accurate pKa assignment for polyprotic molecules (e.g., peptides, phosphonates).
Is method validation support included?
Yes—the system ships with IQ/OQ/PQ protocols, reference standards (certified pKa buffers), and a 21 CFR Part 11 compliance package including risk assessment documentation and URS/FS/DS templates.
What maintenance is required for the microprobe array?
Probes undergo automated cleaning cycles between samples; annual recalibration of UV pathlength and pH electrode slope is recommended using NIST-traceable standards.
How does the SiriusT3 handle highly viscous or particulate-containing samples?
Integrated ultrasonic probe sonication (20 kHz, 30 s) and magnetic stirring (300 rpm) ensure homogeneous dispersion prior to measurement; turbidity compensation algorithms correct for light scattering effects in absorbance readings.